Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life

van der Heide, 2007, Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer, Radiother Oncol, 82, 38, 10.1016/j.radonc.2006.11.002 McNair, 2008, A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy, Int J Radiat Oncol Biol Phys, 71, 41, 10.1016/j.ijrobp.2007.09.002 van der Vight, 2009, Off-line setup corrections only marginally reduce the number of on-line corrections for prostate radiotherapy using implanted gold markers, Radiother Oncol, 90, 359, 10.1016/j.radonc.2008.09.005 Kotte, 2007, Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers, Int J Radiat Oncol Biol Phys, 69, 419, 10.1016/j.ijrobp.2007.03.029 Lips, 2007, Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study, Int J Radiat Oncol Biol Phys, 69, 656, 10.1016/j.ijrobp.2007.04.013 Lips, 2008, High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients, Radiat Oncol, 3, 15, 10.1186/1748-717X-3-15 Al Mamgani, 2008, Update of Dutch multicenter dose–escalation trial of radiotherapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, 72, 980, 10.1016/j.ijrobp.2008.02.073 Poggi, 2003, Marker seed migration in prostate localization, Int J Radiat Oncol Biol Phys, 56, 1248, 10.1016/S0360-3016(03)00328-6 Nichol, 2007, A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers, Int J Radiat Oncol Biol Phys, 67, 48, 10.1016/j.ijrobp.2006.08.021 Dehnad, 2003, Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation, Radiother Oncol, 67, 295, 10.1016/S0167-8140(03)00078-1 Hornbrook, 1995, Assessing relative health plan risk with the RAND-36 health survey, Inquiry, 32, 56 Aaronson, 1998, Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations, J Clin Epidemiol, 51, 1055, 10.1016/S0895-4356(98)00097-3 Borghede, 1996, Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30, Qual Life Res, 5, 212, 10.1007/BF00434743 van Andel, 2008, An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer, Eur J Cancer, 44, 2418, 10.1016/j.ejca.2008.07.030 Langenhuijsen, 2007, Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors, Int J Radiat Oncol Biol Phys, 69, 671, 10.1016/j.ijrobp.2007.04.009 Osoba, 2005, Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group, Eur J Cancer, 41, 280, 10.1016/j.ejca.2004.10.017 Henry, 2004, Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy, Radiother Oncol, 73, 57, 10.1016/j.radonc.2004.08.007 Hara, 2008, Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy, Urology, 71, 191, 10.1016/j.urology.2007.09.029 Nederveen, 2003, Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials, Radiother Oncol, 68, 81, 10.1016/S0167-8140(03)00129-4 Kitamura, 2002, Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT), Radiother Oncol, 62, 275, 10.1016/S0167-8140(02)00017-8 Pouliot, 2003, (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device, Int J Radiat Oncol Biol Phys, 56, 862, 10.1016/S0360-3016(03)00267-0